MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes

N. Vokes; E. Jimenez Alguilar; A. Adeni; R. Umeton; L. Sholl; H. Rizvi; M. Hellmann; M. Awad; E. Van Allen

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes

【24h】

MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes

机译：Ma19.01患有靶向诱导物的非小细胞肺癌抗PD1 / PD-L1阻断的疗效和基因组相关性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
作者
N. Vokes; E. Jimenez Alguilar; A. Adeni; R. Umeton; L. Sholl; H. Rizvi; M. Hellmann; M. Awad; E. Van Allen;
展开▼
作者单位

Dana Farber Cancer Institute Boston;

University Hospital 12 de Octubre;

Dana Farber Cancer Institute Boston;

Dana Farber Cancer Institute Boston;

Pathology Brigham and Women’s Hospital Boston;

Memorial Sloan Kettering Cancer Center New York;

Memorial Sloan Kettering Cancer Center New York;

Dana Farber Cancer Institute Boston;

Broad Institute;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes [J] . N. Vokes, E. Jimenez Alguilar, A. Adeni, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：Ma19.01患有靶向诱导物的非小细胞肺癌抗PD1 / PD-L1阻断的疗效和基因组相关性
2. Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis [J] . Gianoncelli Letizia, Spitaleri Gianluca, Passaro Antonio, Anticancer Research: International Journal of Cancer Research and Treatment . 2020,第1期

机译：抗PD1 / PD-L1治疗（IO）在KRAS突变体非小细胞肺癌患者中的疗效：回顾性分析
3. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy [J] . Wu Si-Pei, Liao Ri-Qiang, Tu Hai-Yan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第4期

机译：基质PD-L1阳性调节性T细胞和PD-1阳性CD8阳性T细胞定义了非小细胞肺癌不同亚群的响应至PD-1 / PD-L1阻断免疫疗法
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Regulation and Consequences of PD-L1 Expression in Non-Small Cell Lung Cancer [D] . Lastwika, Kristin J. 2014

机译：PD-L1表达在非小细胞肺癌中的调节及后果
6. Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer [O] . Maria Jove, Noelia Vilariño, Ernest Nadal 2019

机译：基线类固醇对晚期非小细胞肺癌患者程序性细胞死亡1（PD-1）和程序性死亡配体1（PD-L1）阻断疗效的影响
7. Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis [O] . LETIZIA GIANONCELLI, GIANLUCA SPITALERI, ANTONIO PASSARO, 2019

机译：抗PD1 / PD-L1治疗（IO）在KRAS突变体非小细胞肺癌患者的疗效：回顾性分析

MA19.01 Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes

著录项

相似文献

相关主题

期刊订阅